Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension
Dysregulation of microRNAs is associated with pulmonary hyperten-sion. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum levels of apelin, kynurenine, and endocan in pulmonary hyp...
Saved in:
Published in | Anatolian journal of cardiology Vol. 26; no. 5; pp. 388 - 393 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Turkey
Turkish Society of Cardiology
01.05.2022
KARE Publishing |
Subjects | |
Online Access | Get full text |
ISSN | 2149-2271 2149-2263 2149-2271 |
DOI | 10.5152/AnatolJCardiol.2021.861 |
Cover
Loading…
Abstract | Dysregulation of microRNAs is associated with pulmonary hyperten-sion. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum levels of apelin, kynurenine, and endocan in pulmonary hypertension.
The study design was prospective and single-centered. The study included 32 consecutive treatment-naive patients with precapillary pulmonary hypertension and 55 age and sex-matched healthy controls. All subjects underwent right heart catheter-ization. mRNA expressions of hypoxia-inducible factor-1 alpha, hypoxia-inducible fac-tor-2 alpha, signal transducer and activator of transcription-3, fibroblast growth factor-2, fibroblast growth factor receptor-1, and poly-ADP-ribose polymerase-1 and microRNA expressions of miRNA-210, miRNA-130a, miRNA-424, miRNA-204, and miRNA-223 weredetermined by RT-PCR. Concentrations of kynurenine, apelin, and endocan were ana-lyzed by ELISA.
mRNA expressions of hypoxia-inducible factor-2 alpha, signal transducer and activator of transcription-33, and FGF-2 were increased; miRNA-210 and miRNA-130a were increased; miRNA-223 and miRNA-204 were decreased in pulmonary hyperten-sion. Apelin and kynurenine concentrations were decreased in pulmonary hypertension. There were positive correlations: hypoxia-inducible factor-2 alpha-miRNA-424, Apelin- miRNA-424, kynurenine-miRNA-210, signal transducer and activator of transcription- 3-PVR, miRNA-210-right atrial pressure, and kynurenine-right atrial pressure. There were negative correlations: poly-ADP-ribose polymerase-1-miRNA-210 and poly-ADP-ribose polymerase-1-right atrial pressure. On multiple logistic regression analyses, miRNA-130a and Apelin were independent risk factors for PH.
We report a novel relationship between the kynurenine and poly-ADP- ribose polymerase-1 signaling pathways that could be mediated by miRNA-210. We also report a connection between the Apelin and hypoxia-inducible factor-2 alpha signaling pathways that could be mediated by miRNA-424. Reduced levels of Apelin and elevated levels of miRNA-130a are associated with pulmonary hypertension. We also find that ele-vated levels of signal transducer and activator of transcription-3, miRNA-210, and kyn-urenine and reduced levels of poly-ADP-ribose polymerase-1 correlate with more severe hemodynamics. |
---|---|
AbstractList | Dysregulation of microRNAs is associated with pulmonary hyperten-sion. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum levels of apelin, kynurenine, and endocan in pulmonary hypertension.BACKGROUNDDysregulation of microRNAs is associated with pulmonary hyperten-sion. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum levels of apelin, kynurenine, and endocan in pulmonary hypertension.The study design was prospective and single-centered. The study included 32 consecutive treatment-naive patients with precapillary pulmonary hypertension and 55 age and sex-matched healthy controls. All subjects underwent right heart catheter-ization. mRNA expressions of hypoxia-inducible factor-1 alpha, hypoxia-inducible fac-tor-2 alpha, signal transducer and activator of transcription-3, fibroblast growth factor-2, fibroblast growth factor receptor-1, and poly-ADP-ribose polymerase-1 and microRNA expressions of miRNA-210, miRNA-130a, miRNA-424, miRNA-204, and miRNA-223 weredetermined by RT-PCR. Concentrations of kynurenine, apelin, and endocan were ana-lyzed by ELISA.METHODSThe study design was prospective and single-centered. The study included 32 consecutive treatment-naive patients with precapillary pulmonary hypertension and 55 age and sex-matched healthy controls. All subjects underwent right heart catheter-ization. mRNA expressions of hypoxia-inducible factor-1 alpha, hypoxia-inducible fac-tor-2 alpha, signal transducer and activator of transcription-3, fibroblast growth factor-2, fibroblast growth factor receptor-1, and poly-ADP-ribose polymerase-1 and microRNA expressions of miRNA-210, miRNA-130a, miRNA-424, miRNA-204, and miRNA-223 weredetermined by RT-PCR. Concentrations of kynurenine, apelin, and endocan were ana-lyzed by ELISA.mRNA expressions of hypoxia-inducible factor-2 alpha, signal transducer and activator of transcription-33, and FGF-2 were increased; miRNA-210 and miRNA-130a were increased; miRNA-223 and miRNA-204 were decreased in pulmonary hyperten-sion. Apelin and kynurenine concentrations were decreased in pulmonary hypertension. There were positive correlations: hypoxia-inducible factor-2 alpha-miRNA-424, Apelin- miRNA-424, kynurenine-miRNA-210, signal transducer and activator of transcription- 3-PVR, miRNA-210-right atrial pressure, and kynurenine-right atrial pressure. There were negative correlations: poly-ADP-ribose polymerase-1-miRNA-210 and poly-ADP-ribose polymerase-1-right atrial pressure. On multiple logistic regression analyses, miRNA-130a and Apelin were independent risk factors for PH.RESULTSmRNA expressions of hypoxia-inducible factor-2 alpha, signal transducer and activator of transcription-33, and FGF-2 were increased; miRNA-210 and miRNA-130a were increased; miRNA-223 and miRNA-204 were decreased in pulmonary hyperten-sion. Apelin and kynurenine concentrations were decreased in pulmonary hypertension. There were positive correlations: hypoxia-inducible factor-2 alpha-miRNA-424, Apelin- miRNA-424, kynurenine-miRNA-210, signal transducer and activator of transcription- 3-PVR, miRNA-210-right atrial pressure, and kynurenine-right atrial pressure. There were negative correlations: poly-ADP-ribose polymerase-1-miRNA-210 and poly-ADP-ribose polymerase-1-right atrial pressure. On multiple logistic regression analyses, miRNA-130a and Apelin were independent risk factors for PH.We report a novel relationship between the kynurenine and poly-ADP- ribose polymerase-1 signaling pathways that could be mediated by miRNA-210. We also report a connection between the Apelin and hypoxia-inducible factor-2 alpha signaling pathways that could be mediated by miRNA-424. Reduced levels of Apelin and elevated levels of miRNA-130a are associated with pulmonary hypertension. We also find that ele-vated levels of signal transducer and activator of transcription-3, miRNA-210, and kyn-urenine and reduced levels of poly-ADP-ribose polymerase-1 correlate with more severe hemodynamics.CONCLUSIONSWe report a novel relationship between the kynurenine and poly-ADP- ribose polymerase-1 signaling pathways that could be mediated by miRNA-210. We also report a connection between the Apelin and hypoxia-inducible factor-2 alpha signaling pathways that could be mediated by miRNA-424. Reduced levels of Apelin and elevated levels of miRNA-130a are associated with pulmonary hypertension. We also find that ele-vated levels of signal transducer and activator of transcription-3, miRNA-210, and kyn-urenine and reduced levels of poly-ADP-ribose polymerase-1 correlate with more severe hemodynamics. Background: Dysregulation of microRNAs is associated with pulmonary hypertension. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum levels of apelin, kynurenine, and endocan in pulmonary hypertension. Methods: The study design was prospective and single-centered. The study included 32 consecutive treatment-naive patients with precapillary pulmonary hypertension and 55 age and sex-matched healthy controls. All subjects underwent right heart catheterization. mRNA expressions of hypoxia-inducible factor-1 alpha, hypoxia-inducible factor-2 alpha, signal transducer and activator of transcription-3, fibroblast growth factor-2, fibroblast growth factor receptor-1, and poly-ADP-ribose polymerase-1 and microRNA expressions of miRNA-210, miRNA-130a, miRNA-424, miRNA-204, and miRNA-223 were determined by RT-PCR. Concentrations of kynurenine, apelin, and endocan were analyzed by ELISA. Results: mRNA expressions of hypoxia-inducible factor-2 alpha, signal transducer and activator of transcription-33, and FGF-2 were increased; miRNA-210 and miRNA-130a were increased; miRNA-223 and miRNA-204 were decreased in pulmonary hypertension. Apelin and kynurenine concentrations were decreased in pulmonary hypertension. There were positive correlations: hypoxia-inducible factor-2 alpha-miRNA-424, ApelinmiRNA-424, kynurenine-miRNA-210, signal transducer and activator of transcription-3-PVR, miRNA-210-right atrial pressure, and kynurenine-right atrial pressure. There were negative correlations: poly-ADP-ribose polymerase-1-miRNA-210 and poly-ADP-ribose polymerase-1-right atrial pressure. On multiple logistic regression analyses, miRNA-130a and Apelin were independent risk factors for PH. Conclusions: We report a novel relationship between the kynurenine and poly-ADPribose polymerase-1 signaling pathways that could be mediated by miRNA-210. We also report a connection between the Apelin and hypoxia-inducible factor-2 alpha signaling pathways that could be mediated by miRNA-424. Reduced levels of Apelin and elevated levels of miRNA-130a are associated with pulmonary hypertension. We also find that elevated levels of signal transducer and activator of transcription-3, miRNA-210, and kynurenine and reduced levels of poly-ADP-ribose polymerase-1 correlate with more severe hemodynamics Dysregulation of microRNAs is associated with pulmonary hyperten-sion. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum levels of apelin, kynurenine, and endocan in pulmonary hypertension. The study design was prospective and single-centered. The study included 32 consecutive treatment-naive patients with precapillary pulmonary hypertension and 55 age and sex-matched healthy controls. All subjects underwent right heart catheter-ization. mRNA expressions of hypoxia-inducible factor-1 alpha, hypoxia-inducible fac-tor-2 alpha, signal transducer and activator of transcription-3, fibroblast growth factor-2, fibroblast growth factor receptor-1, and poly-ADP-ribose polymerase-1 and microRNA expressions of miRNA-210, miRNA-130a, miRNA-424, miRNA-204, and miRNA-223 weredetermined by RT-PCR. Concentrations of kynurenine, apelin, and endocan were ana-lyzed by ELISA. mRNA expressions of hypoxia-inducible factor-2 alpha, signal transducer and activator of transcription-33, and FGF-2 were increased; miRNA-210 and miRNA-130a were increased; miRNA-223 and miRNA-204 were decreased in pulmonary hyperten-sion. Apelin and kynurenine concentrations were decreased in pulmonary hypertension. There were positive correlations: hypoxia-inducible factor-2 alpha-miRNA-424, Apelin- miRNA-424, kynurenine-miRNA-210, signal transducer and activator of transcription- 3-PVR, miRNA-210-right atrial pressure, and kynurenine-right atrial pressure. There were negative correlations: poly-ADP-ribose polymerase-1-miRNA-210 and poly-ADP-ribose polymerase-1-right atrial pressure. On multiple logistic regression analyses, miRNA-130a and Apelin were independent risk factors for PH. We report a novel relationship between the kynurenine and poly-ADP- ribose polymerase-1 signaling pathways that could be mediated by miRNA-210. We also report a connection between the Apelin and hypoxia-inducible factor-2 alpha signaling pathways that could be mediated by miRNA-424. Reduced levels of Apelin and elevated levels of miRNA-130a are associated with pulmonary hypertension. We also find that ele-vated levels of signal transducer and activator of transcription-3, miRNA-210, and kyn-urenine and reduced levels of poly-ADP-ribose polymerase-1 correlate with more severe hemodynamics. |
Author | Yaylalı, Yalın Tolga Seçme, Mücahit Dodurga, Yavuz Şenol, Hande Akgün, Alperen Emre |
Author_xml | – sequence: 1 givenname: Alperen Emre surname: Akgün fullname: Akgün, Alperen Emre organization: Department of Cardiology, Uşak Training and Research Hospital, Uşak, Turkey – sequence: 2 givenname: Yalın Tolga surname: Yaylalı fullname: Yaylalı, Yalın Tolga organization: Department of Cardiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey – sequence: 3 givenname: Mücahit surname: Seçme fullname: Seçme, Mücahit organization: Department of Medical Biology, Faculty of Medicine, Pamukkale University, Denizli, Turkey – sequence: 4 givenname: Yavuz surname: Dodurga fullname: Dodurga, Yavuz organization: Department of Medical Biology, Faculty of Medicine, Pamukkale University, Denizli, Turkey – sequence: 5 givenname: Hande surname: Şenol fullname: Şenol, Hande organization: Department of Biostatistics, Faculty of Medicine, Pamukkale University, Denizli, Turkey |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35552175$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkVtv1DAQhS1URC_0L4Afecnicew4fkFalksLu7Cq4BFFvkwWl6y9OEml_HtCW1A7LzOaOfrOkeaUHMUUkZCXwBYSJH-9jGZI3aeVyT6kbsEZh0VdwRNywkHognMFRw_mY3Le99eMMVBlDVA9I8ellJKDkifkx-cpjhljiFhsl1fbAug6xF90gz6YAT21E90El9PVlyXlwOjGTPQt0ndTn3E3dreaEOl27PYpmjzRi-mAecDYhxSfk6et6Xo8v-9n5PuH999WF8X668fL1XJdOAHlUEgnvELnK96y2lrgHIV2rauda1Ewh4q3bcuMBaHA2sqB0saXTEmEGnldnpHLO65P5ro55LCfkzTJhOZ2kfKuMXkIrsOGl144Z7WsvBOistrpFuaqQDOrajOz3tyxDqPdo3cYh2y6R9DHlxh-Nrt00-iyqgT8DfPqHpDT7xH7odmH3mHXmYhp7Bs-y5RWUqtZ-uKh13-Tf_8p_wCgUpiY |
CitedBy_id | crossref_primary_10_1007_s12672_024_01723_5 |
ContentType | Journal Article |
Copyright | Copyright 2022 authors 2022 authors |
Copyright_xml | – notice: Copyright 2022 authors 2022 authors |
DBID | CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.5152/AnatolJCardiol.2021.861 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2149-2271 |
EndPage | 393 |
ExternalDocumentID | oai_doaj_org_article_23d4ccb956dc446b9c9f11116190b78a PMC9366418 35552175 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 7X7 88E 8FI 8FJ 8G5 ABDBF ABUWG ACUHS ADBBV AENEX AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BCNDV BENPR BPHCQ BVXVI CCPQU CGR CUY CVF DWQXO EAD EAP EAS EBD ECM EDSIH EIF EMB EMK EMOBN EOJEC ESX FYUFA GNUQQ GROUPED_DOAJ GUQSH HMCUK HYE M1P M2O NPM OBODZ OK1 PADUT PHGZT PIMPY PQQKQ PROAC PSQYO RPM SV3 TUS UKHRP 7X8 5PM |
ID | FETCH-LOGICAL-c413t-5c4d7ecd62f08bb122e49cfc8ccfe40ce72fff0ab1471bb6c179ad3075e18e283 |
IEDL.DBID | DOA |
ISSN | 2149-2271 2149-2263 |
IngestDate | Wed Aug 27 01:25:46 EDT 2025 Thu Aug 21 18:43:02 EDT 2025 Fri Jul 11 02:23:34 EDT 2025 Thu Apr 03 07:01:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c413t-5c4d7ecd62f08bb122e49cfc8ccfe40ce72fff0ab1471bb6c179ad3075e18e283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Cite this article as: Akgün AE, Yaylalı YT, Seçme M, Dodurga Y, Şenol H. Kynurenine–PARP-1 link mediated by MicroRNA 210 may be dysregulated in pulmonary hypertension. Anatol J Cardiol 2022;26(5):388-393. |
ORCID | 0000-0002-2084-760X 0000-0002-4936-5954 0000-0001-8819-5217 0000-0001-6395-7924 0000-0002-8452-923X |
OpenAccessLink | https://doaj.org/article/23d4ccb956dc446b9c9f11116190b78a |
PMID | 35552175 |
PQID | 2664797597 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_23d4ccb956dc446b9c9f11116190b78a pubmedcentral_primary_oai_pubmedcentral_nih_gov_9366418 proquest_miscellaneous_2664797597 pubmed_primary_35552175 |
PublicationCentury | 2000 |
PublicationDate | 2022-05-01 |
PublicationDateYYYYMMDD | 2022-05-01 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Turkey |
PublicationPlace_xml | – name: Turkey |
PublicationTitle | Anatolian journal of cardiology |
PublicationTitleAlternate | Anatol J Cardiol |
PublicationYear | 2022 |
Publisher | Turkish Society of Cardiology KARE Publishing |
Publisher_xml | – name: Turkish Society of Cardiology – name: KARE Publishing |
SSID | ssj0001738116 |
Score | 2.2407622 |
Snippet | Dysregulation of microRNAs is associated with pulmonary hyperten-sion. The present study aimed to determine the alterations in microRNA and microRNA... Background: Dysregulation of microRNAs is associated with pulmonary hypertension. The present study aimed to determine the alterations in microRNA and microRNA... |
SourceID | doaj pubmedcentral proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 388 |
SubjectTerms | Adenosine Diphosphate Ribose Apelin Humans Hypertension, Pulmonary - genetics Hypertension, Pulmonary - metabolism Hypoxia Kynurenine microrna MicroRNAs - genetics Original Investigation Poly(ADP-ribose) Polymerase Inhibitors Poly(ADP-ribose) Polymerases - metabolism poly-adp-ribose polymerase-1 Prospective Studies pulmonary hypertension RNA, Messenger |
Title | Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35552175 https://www.proquest.com/docview/2664797597 https://pubmed.ncbi.nlm.nih.gov/PMC9366418 https://doaj.org/article/23d4ccb956dc446b9c9f11116190b78a |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LahsxFL20KZRuSt91H0aFbqceyZqRZmnHNk7KGOPW4N0wetFAkINjL2bXf-gf5ktypXGLXQLZZKkHI6Ercc4ZXd0L8FVapRBn8iRPNUu4YjJR2tYJVlKH_NiYfniNXM7y6ZKfr7LVQaqv4BPWhgduF67H-oZrrZDGG43SRRW6cOGYI_FPlZCRGiHmHYip-HdFIBLRvHXoQshmvYFHEXt5fhq9PMOdA6PfZAyNHYa8i1_-7yZ5gDuTF_B8TxjJoJ3oS3hk_St4Wu6vxF9D9b0Jb309Fm5-_5kPFvOEkqAwSRmzcFhDVEPK4He3mA0Iai9S1g0ZWjJqEB5jJnrsc-HJfHeJe7LeNGSK4nQTXdvX_g0sJ-Ofp9NknzUh0QhI2yTT3AirTc5cKtEQjFleaKel1s7yVFvBnHNprSjiklK5xiNZGzzqmaXSItt4Cyd-7e17IK42WWzTPOe1s7JvGHeZTVGUUG5oB4Zh8aqrNjBGFUJVxwo0YLU3YHWfATvw5e_SV7i1w31F7e16d10hd-CiECh5OvCuNcW_oZAmIfEQWQfEkZGO5nLc4i9-xfDZRR-_S-WHh5j8R3jGwnuI6AH5CU62m539jCxlq7rwWKxEF54Mx7P5ohu3J5bGox9n01tyCuy8 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kynurenine%E2%80%93PARP-1+Link+Mediated+by+MicroRNA+210+May+Be+Dysregulated+in+Pulmonary+Hypertension&rft.jtitle=Anatolian+journal+of+cardiology&rft.au=Alperen+Emre+Akgun&rft.au=Yal%C4%B1n+Tolga+Yaylal%C4%B1&rft.au=M%C3%BCcahit+Se%C3%A7me&rft.au=Yavuz+Dodurga&rft.date=2022-05-01&rft.pub=KARE+Publishing&rft.eissn=2149-2271&rft.volume=26&rft.issue=5&rft.spage=388&rft.epage=393&rft_id=info:doi/10.5152%2FAnatolJCardiol.2021.861&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_23d4ccb956dc446b9c9f11116190b78a |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2149-2271&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2149-2271&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2149-2271&client=summon |